Rachael McCool
Overview
Explore the profile of Rachael McCool including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fitzgerald A, McCool R, Carr E, Miller P, Reddish K, Lohr C, et al.
N Am Spine Soc J
. 2025 Feb;
21:100579.
PMID: 39917175
Background: Degenerative disc disease (DDD) is associated with chronic lower back pain that may have impacts on individual's quality of life and functional ability. Lumbar interbody fusion can be carried...
2.
Sharp A, Sanderson A, Hansell N, Reddish K, Miller P, Moss J, et al.
J Hypertens
. 2024 Oct;
42(12):2215-2217.
PMID: 39469925
No abstract available.
3.
Chappell M, Sanderson A, Arun T, Green C, Davies H, Tempest M, et al.
J Neurol Sci
. 2024 Aug;
464:123172.
PMID: 39142083
Background: Highly active (HA) relapsing remitting multiple sclerosis (RRMS) is associated with frequent relapses and high burden of disease/disability. Natalizumab is licensed for HA RRMS, including rapidly evolving severe (RES)...
4.
Sharp A, Sanderson A, Hansell N, Reddish K, Miller P, Moss J, et al.
J Hypertens
. 2024 Apr;
42(7):1133-1144.
PMID: 38634457
This systematic review and meta-analysis was conducted to assess the randomized controlled trial (RCT) evidence available for renal denervation (RDN) in uncontrolled arterial hypertension. Twenty-five RCTs met the eligibility criteria...
5.
Phalguni A, McCool R, Wood H, Sanderson A, Rydevik G, Franklin B, et al.
Int Clin Psychopharmacol
. 2022 Aug;
38(1):45-56.
PMID: 35916575
A systematic review was undertaken to identify randomized controlled trials (RCTs) comparing the efficacy and safety of lurasidone, brexpiprazole and cariprazine (selected because of a shared safety profile) with each...
6.
Herbst R, Jassem J, Abogunrin S, James D, McCool R, Belleli R, et al.
Front Oncol
. 2021 Jul;
11:676732.
PMID: 34307144
In the absence of head-to-head trials of first-line treatments for metastatic non-small cell lung cancer (NSCLC), synthesis of available evidence is needed. We conducted a systematic literature review and network...
7.
Zasowski E, Bassetti M, Blasi F, Rello J, Sotgiu G, Tavoschi L, et al.
Chest
. 2021 May;
159(4):1677-1678.
PMID: 34021997
No abstract available.
8.
Palacios-Baena Z, Giannella M, Manissero D, Rodriguez-Bano J, Viale P, Lopes S, et al.
Clin Microbiol Infect
. 2020 Nov;
27(2):228-235.
PMID: 33130270
Background: Rapid and widespread increases in carbapenem resistance (CR) necessitate identification of risk factors to guide appropriate interventions. Objectives: We aimed to identify risk factors for CR Gram-negative infection through...
9.
Bassetti M, Rello J, Blasi F, Goossens H, Sotgiu G, Tavoschi L, et al.
Int J Antimicrob Agents
. 2020 Oct;
56(6):106184.
PMID: 33045353
We investigated the impact of appropriate versus inappropriate initial antimicrobial therapy on the clinical outcomes of patients with severe bacterial infections as part of a systematic review and meta-analyses assessing...
10.
Du Jardin K, Hurtado Lopez P, Lange M, McCool R, Maeso Naval S, Quickert S
J Health Econ Outcomes Res
. 2020 Aug;
7(2):123-129.
PMID: 32766377
Background: Psoriasis is a chronic inflammatory skin condition that impacts quality of life and requires long-term treatment and effective symptom management. Interleukin-23 (IL-23) has emerged as a key player in...